Chief Executive Officer, Northwest Biotherapeutics
Ms. Powers has served as the Chairman of NW Bio since 2007, and as CEO since 2011. Ms. Powers previously served as a Managing Director of Toucan Capital Fund II, an investment fund focused on regenerative medicine and immune therapies, from 2001 to 2010. In addition, she has over 15 years’ experience in corporate finance and restructurings, mergers and acquisitions, joint ventures and intellectual property licensing. Ms. Powers has served for many years on a number of boards and commissions, including M2GEN (an affiliate of Moffitt Cancer Center), the Chinese Biopharmaceutical Association, the Rosalind Franklin Society, the Maryland Stem Cell Research Commission, a Steering Committee of the National Academy of Sciences evaluating government research funding, and three Governors’ commissions focused on building biotech and other industries. Ms. Powers taught for more than six years at the National Institutes of Health, on medical product development and commercialization, and at Georgetown Law School as an adjunct professor. Ms. Powers serves on the boards of a number of private biotechnology companies. Ms. Powers holds a B.A. from Princeton University, magna cum laude, and a J.D. from Harvard Law School, magna cum laude.